ARSENIA RIVERA-MANZI: Open Payments
NPI 1205893534 · WESTBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 75 payments from 13 companies in 2025. Trend: 2023 $1,864 · 2024 $1,938 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $315 |
| AstraZeneca Pharmaceuticals LP | 14 | $289 |
| Novo Nordisk Inc | 12 | $243 |
| Amgen Inc. | 13 | $227 |
| Lilly USA, LLC | 7 | $213 |
| ABBVIE INC. | 7 | $158 |
| Ardelyx, Inc. | 3 | $72 |
| Exact Sciences Corporation | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: JARDIANCE, FARXIGA, MOUNJARO, Wegovy, OTEZLA, QULIPTA, REPATHA, IBSRELA.
Industry payments across NY — which companies pay providers there.
